News | Treatment Planning | July 21, 2017

Latest version of RayStation includes proton-specific features including fast Monte Carlo pencil beam scanning optimization and dose calculation

Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning

July 21, 2017 — RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation as their treatment planning system.

Six of the orders were received in June 2017:

  • The Children’s Cancer Hospital Foundation (Cairo, Egypt);
  • Hospital Quirónsalud (Madrid, Spain);
  • Mayo Clinic Hospital (Phoenix, Ariz.);
  • ZON-PTC (Maastricht, Netherlands);
  • MedStar Georgetown University Hospital (Washington, D.C.); and
  • The Johns Hopkins Medicine proton center at Sibley Memorial Hospital (Washington, D.C.)

RayStation was also recently selected by Tata Memorial Center in Mumbai, one of India’s first proton therapy facilities, and PLA General Hospital in Beijing, China. A total of 35 proton centers have purchased RayStation so far, and this constitutes more than half of the existing proton centers in the world, according to the company.

These eight centers represent a variety of hospital environments and machine types. RayStation will be used together with the IBA Proteus Plus and Proteus One systems, Mevion systems with Hyperscan and Hitachi ProBeat systems.

The centers will receive the latest version of RayStation, which includes features such as fast Monte Carlo pencil beam scanning (PBS) optimization and dose calculation, use of PBS with apertures, and robust optimization/4D-CT (computed tomography) optimization for proton and carbon ion planning. All purchases include both clinical and research licenses.

RayStation has a wide range of features of value to researchers at academic centers. A few examples are LET and RBE calculations for proton and carbon PBS planning, interplay evaluation from machine delivery log files, positron emission tomography (PET)-based range verification, proton and carbon planning on virtual cone beam computed tomography (CBCT) images and small animal X-ray irradiator planning.

The clinical and research configurations of RayStation will be on show at the upcoming American Association of Physicists in Medicine (AAPM) Annual Meeting, July 30-Aug. 2 in Denver.

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
News | Proton Therapy

September 28, 2023 — Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, will ...

Time September 28, 2023
arrow
News | Radiopharmaceuticals and Tracers

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
News | Radiation Therapy

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Subscribe Now